Speaker - Andrew C. von Eschenbach

 Andrew C. von Eschenbach  Thumbnail


Andrew C. von Eschenbach, M.D., was sworn in as the 20th commissioner of the U.S. Food and Drug Administration on December 13, 2006. As commissioner, he leads the nation's premiere consumer protection and health agency, regulating products that account for more than 20% of consumer spending. As the former Director of the National Cancer Institute (NCI), Dr. von Eschenbach is a nationally recognized urologic surgeon and oncologist. His distinguished career as a key leader in the fight against cancer spans nearly three decades. Prior to being appointed to lead the NCI in January 2002, Dr. von Eschenbach served as executive vice president and chief academic officer of the University of Texas M.D. Anderson Cancer Center in Houston, leading a faculty of more than 1,000 cancer researchers and clinicians. At M.D. Anderson he also served as vice president for academic affairs and held the Roy M. and Phyllis Gough Huffington Clinical Research Distinguished Chair in Urologic Oncology. Dr. von Eschenbach, as founding director of the Prostate Cancer Research Program, was instrumental in fostering integrated research programs in the biology, epidemiology, prevention, and treatment of prostate cancer at M.D. Anderson. where he also directed the Genitourinary Cancer Center. He joined M.D. Anderson as a urologic oncology fellow in 1976 and was invited to join the faculty the following year. Just six years later - in 1983 - he was named chairman of the Department of Urology. Other positions von Eschenbach held at M.D. Anderson include Consulting Professor of Cell Biology and Professor of Urology. Dr. von Eschenbach, himself a cancer survivor, has had an impact on the fight against cancer that extends beyond the clinical and academic communities. He is a founding member of C-Change and was president-elect of the American Cancer Society at the time of his appointment to the NCI. In addition, he has made significant contributions to scientific literature: more than 200 articles, books, and book chapters. Dr. von Eschenbach has also served as an editorial board member of several leading journals and on several organizational boards.

1 Program

Dr. Andrew von Eschenbach: Modernizing the FDA

06.10.08 | 01:04:39 min | 0 comments